miércoles, 27 de diciembre de 2023

FDA approves topical treatment for junctional, dystrophic epidermolysis bullosa Doug Brunk

https://www.medscape.com/s/viewarticle/fda-approves-topical-treatment-junctional-dystrophic-2023a1000wlt?ecd=wnl_edit_tpal_etid6196075&uac=148436CN&impID=6196075

No hay comentarios:

Publicar un comentario